Halma Financial Highlights
- Revenue: GBP 2.03 billion, up 9.8% year-on-year (YoY), exceeding the estimate of GBP 1.99 billion.
- Environmental & Analysis Revenue: GBP 658.4 million, up 19% YoY, beating the estimate of GBP 598.7 million.
- Medical Revenue: GBP 552.9 million, down 0.6% YoY, missing the estimate of GBP 578.7 million.
- Safety Revenue: GBP 823.8 million, up 10% YoY, surpassing the estimate of GBP 812.5 million.
- Adjusted Pretax Profit: GBP 396.4 million, up 9.7% YoY, above the estimate of GBP 388.8 million.
- Statutory Pretax Profit: GBP 340.3 million, up 17% YoY, slightly exceeding the estimate of GBP 337.5 million.
- Adjusted EPS: 82.40 pence compared to 76.34 pence YoY, beating the estimate of 80.53 pence.
- Final Dividend Per Share: 13.20 pence.
- Total Dividend Per Share: 21.61 pence, up from 20.20 pence YoY, close to the estimate of 21.63 pence.
A look at Halma PLC Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Halma PLC shows a promising long-term outlook. With a strong momentum score of 5, the company is indicating robust growth potential and positive market sentiment. Additionally, Halma received a high growth score of 4, pointing towards the company’s capacity for sustained expansion and development.
While the value and dividend scores are moderate at 2 each, the resilience score of 3 highlights Halma’s ability to weather market challenges and maintain stability. Overall, Halma PLC, a health and safety sensor technology group, appears well-positioned for future growth and success in its sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
